Skip to main content

Table 1 Demographics and disease characteristics

From: Treatment of glioblastoma multiforme with “classic” 4:1 ketogenic diet total meal replacement

Gender (M, %)   6 (75)
Age, years 40s n = 5
60s n = 3
Race Caucasian/white 5
Caucasian/Hispanic 1
Asian Indian 2
Group1 Group 1 4
Group 2 4
GBM primary/secondary Primary 6
Secondary 2 (both in group 2)
IDH 12 mutational status Negative 6
Unknown 2
MGMT3 promoter methylation status Negative 5
Positive 2
Unknown 1
  1. 1Group 1, newly diagnosed GBM, KD concurrent with radiation and temozolomide; group 2, recurrent GBM
  2. 2IDH isocitrate dehydrogenase
  3. 3MGMT O6-methylguanine methyltransferase promoter methylation